本研究開發合成Matrix Metalloproteinase 3 (MMP-3) 胜肽,及其控制組胜肽。利用HPLC純化,再經過質譜儀鑑定結果,其分子量為1842.36 g/ mol,與實際分子量1842.13 g/ mol相符合。在此設計MMP-3 peptide序列,主要是由於MMP-3酵素會針對其Glu-Nval殘基進行切割,而控制組胜肽則否,藉此偵測MMP-3酵素。此外本研究又針對了Bombesin及KGRGD序列,分別合成了DOTA-RGD及TTDA-ITCP-BN, 2個錯合物。其中KGRGD peptide序列利用HPLC純化,經過質譜儀鑑定結果,其分子量為754.29 g/ mol,與實際分子量754.10 g/ mol相符合; 而BN(7-14) peptide序列同樣經過HPLC純化,利用質譜儀鑑定結果,其分子量為1162.55 g/ mol,與實際分子量1162.30 g/ mol相符合。此外,也成功的合成出TTDA-ITCP,利用核磁共振(Nuclear Magnetic Resonance)及質譜儀鑑定,結果相符合。
Matrix Metalloproteinase 3 (MMP-3) and control peptide substrate was designed. To employ HPLC purify, and use mass spectrometer to appraise result. It molecular weight is 1842.36 g/ mol, and intrinsical molecular weight is 1842.13 g/ mol. We designed MMP-3 peptide substrate, as a result of MMP-3 enzyme had cleave Glu-Nval, however control did not . We had aim Bombesin and KGRGD substrate respectively conjugate with DOTA-RGD and TTDA-ITCP-BN. KGRGD peptide substrate had employ HPLC purify, and use mass spectrometer to appraise result. It molecular weight is 754.29 g/ mol, and intrinsical molecular weight is 754.10 g/ mol. BN(7-14) peptide substrate had employ HPLC purify, and use mass spectrometer to appraise result. It molecular weight is 1162.55 g/ mol, and intrinsical molecular weight is 1162.30 g/ mol. In addition, we also designed TTDP-ITCP successful. And had employ NMR (nuclear magnetic resonance ) and mass spectrometer to assay that.